Table 1.
Demographics and Outcomes
| CCSI (n = 126) | EIS (n = 69) | P | |
|---|---|---|---|
| Sex | |||
| Male | 94 (74.6) | 57 (82.6) | |
| Female | 27 (21.4) | 10 (14.5) | |
| Transfemale | 5 (4.0) | 2 (2.9) | .4533 |
| Race | |||
| African American | 81 (64.3) | 48 (69.6) | .7576 |
| White | 30 (23.8) | 14 (20.3) | |
| Latin/other | 15 (11.9) | 7 (10.1) | |
| HIV risk factor | |||
| MSM | 73 (57.9) | 42 (60.9) | .4775 |
| Heterosexual | 48 (38.1) | 22 (31.9) | |
| IDU | 5 (4.0) | 5 (7.2) | |
| Age <25 y | 35 (27.8) | 23 (33.3) | .4171 |
| Age, ya | 29 + 13 (24, 37) | 29 + 13 (24,37) | .9280 |
| Tobacco use | 50 (41.0) | 38 (55.1) | .0606 |
| Alcohol use | 73 (59.8) | 36 (52.2) | .3041 |
| Hypertension | 12 (9.5) | 11 (15.9) | .1840 |
| Diabetes | 4 (3.2) | 3 (4.3) | .6997 |
| Syphilis/GC/CT | 48 (38.1) | 32 (46.4) | .2609 |
| Mental health DX | 25 (20.0) | 23 (33.3) | .0394 |
| Baseline CD4a | 444 + 375 (265, 640) | 271 + 334.5 (124.5, 459) | .0003 |
| Baseline CD4,a % | 25.7 + 16.6 (15.6, 32.2) | 18 + 16 (11.7, 28.3) | .0022 |
| Baseline VLa | 42 600 + 147 000 (14 000, 161 000) | 70 150 + 187 700 (19 300, 207 000) | .2260 |
| Achieved VS | 125 (99.2) | 65 (94.2) | .0539 |
| Median time to VS | 29 + 33 (22, 55) | 28 + 30 (21, 51) | .6441 |
| Continued VS | 113 (89.7) | 53 (76.8) | .0157 b (.0456) c |
| Retained in care | 116 (92.1) | 55 (79.7) | .0120 b (.0365) c |
Bolded values demonstrate clinical significance.
Abbreviations: CCSI, CrescentCare Start Initiative; CT, chlamydia; DX, diagnosis; EIS, Early Intervention Services; GC, gonococcus; IDU, injection drug user; MSM, men who have sex with men; VL, viral load; VS, viral suppression.
aContinuous measures (age, CD4, VL, time to VL) are expressed as median + interquartile range (25th, 75th percentiles).
bUnadjusted.
cAdjusted for tobacco use.